Fig. 2.
Hemoglobin levels during sequential treatment with erythropoeitin stimulating agent, granulocyte stimulating factor and sertraline.
Hemoglobin levels during sequential treatment with erythropoeitin stimulating agent, granulocyte stimulating factor and sertraline.